Enzo Biochem ENZ
$ 0.72
-0.01%
Quarterly report 2024-Q3
added 12-16-2024
Country |
USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSE |
CEO |
Dr. Elazar Rabbani |
Employees in the company |
408 |
Shares |
50.9 K |
Market Cap[1] |
$ 36.6 K |
EBITDA (LTM) |
$ -16.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.